Statistical subtyping of individuals with psychosis has been conducted for over 40
years using clinical data, yet results have largely not been translated and biological
subtype research is now a focus. In this talk, I will question whether a movement
away from clinical subtyping is premature and provide data showing that new subtyping
methods from cancer genetics can be applied into high dimensional clinical data to
reveal insights about illness course and genetic aetiology.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2020 Published by Elsevier Inc.
